Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210093
Status:
COMPLETED
Last Update Posted:
2015-10-16
First Post:
2005-09-13
Brief Title:
A Pharmacokinetic Evaluation Study in Healthy Volunteers
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Single-Center Randomized Crossover Pharmacokinetic Evaluation of the Effect of Single Doses of Intravenous INS37217 Nasally Inhaled INS37217 and Orally Inhaled INS37217 Solution in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous intranasal and inhalation administration and to calculate the relative bioavailability of INS37217 when administered via oral or nasal inhalation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None